indomethacin has been researched along with Actinic Reticuloid Syndrome in 12 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of topical indomethacin on the intensity of UVB- and UVA-induced erythema was measured by reflectance spectrophotometry in 23 patients with polymorphic light eruption." | 7.67 | Effect of indomethacin on UVB- and UVA-induced erythema in polymorphic light eruption. ( Diffey, BL; Farr, PM, 1989) |
| "The effect of topical indomethacin on the intensity of UVB- and UVA-induced erythema was measured by reflectance spectrophotometry in 23 patients with polymorphic light eruption." | 3.67 | Effect of indomethacin on UVB- and UVA-induced erythema in polymorphic light eruption. ( Diffey, BL; Farr, PM, 1989) |
| "The causes of pruritus are numerous including xerosis, drug and photoeruptions, follicular and papular eruptions as well as infestations and infections by a wide range of organisms." | 2.68 | Pruritus in HIV-1 disease: therapy with drugs which may modulate the pattern of immune dysregulation. ( Lee, RB; Skelton, HG; Smith, KJ; Wagner, KF; Yeager, J, 1997) |
| "Treatment with indomethacin, a potent inhibitor of PG biosynthesis, inhibited UV-induced ear swelling, abrogated local immunosuppression, and decreased the amount of PGE2 in the ear skin of XPA-deficient mice." | 1.31 | Possible involvement of enhanced prostaglandin E2 production in the photosensitivity in xeroderma pigmentosum group A model mice. ( Eguchi, N; Horio, T; Inui, T; Kuwamoto, K; Miyauchi-Hashimoto, H; Tanaka, K; Urade, Y, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (58.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Temussi, F | 1 |
| Cermola, F | 1 |
| Dellagreca, M | 1 |
| Iesce, MR | 1 |
| Passananti, M | 1 |
| Previtera, L | 1 |
| Zarrelli, A | 1 |
| Tobia, L | 1 |
| Smith, KJ | 1 |
| Skelton, HG | 1 |
| Yeager, J | 1 |
| Lee, RB | 1 |
| Wagner, KF | 1 |
| Akter, U | 1 |
| Niwa, M | 1 |
| Nose, T | 1 |
| Kaida, T | 1 |
| Matsuno, H | 1 |
| Kozawa, O | 1 |
| Uematsu, T | 1 |
| Kuwamoto, K | 1 |
| Miyauchi-Hashimoto, H | 1 |
| Tanaka, K | 1 |
| Eguchi, N | 1 |
| Inui, T | 1 |
| Urade, Y | 1 |
| Horio, T | 1 |
| Ljunggren, B | 1 |
| Juhlin, L | 1 |
| Shroot, B | 1 |
| Wallace, DJ | 1 |
| Metzger, AL | 1 |
| Klinenberg, JR | 1 |
| Farr, PM | 2 |
| Diffey, BL | 2 |
| Lombardino, JG | 1 |
| Wiseman, EH | 1 |
| Bruinsma, W | 1 |
2 trials available for indomethacin and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
Pruritus in HIV-1 disease: therapy with drugs which may modulate the pattern of immune dysregulation.
Topics: Administration, Cutaneous; Administration, Topical; Anti-Inflammatory Agents; Antipruritics; Cycloox | 1997 |
NSAID usage patterns by rheumatologists in the treatment of SLE.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Clinical Trials as | 1989 |
10 other studies available for indomethacin and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
Determination of photostability and photodegradation products of indomethacin in aqueous media.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Stability; Humans; Hydrolysis; Indomethacin; Oxidation | 2011 |
[The therapeutic problem of cutaneous photosensitization. Considerations on a case of xeroderma pigmentosum].
Topics: Adolescent; Carcinoma, Basal Cell; Female; Humans; Indomethacin; Photosensitivity Disorders; Skin Ne | 1967 |
Effects of several agents on UVB- and UVA plus systemic fluoroquinolone-induced erythema of guinea pig skin evaluated by reflectance colorimetry.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; beta Carotene; Butylated Hydroxytoluene; Colorimetry; | 1998 |
Possible involvement of enhanced prostaglandin E2 production in the photosensitivity in xeroderma pigmentosum group A model mice.
Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cytosol; Dinoprost; Dinoprostone; Disease Models, Anima | 2000 |
Inhibition of ultraviolet and phototoxic dermatitis in the mouse.
Topics: Animals; Aspirin; Betamethasone; Chlorpromazine; Dermatitis; Female; Indomethacin; Mice; Photosensit | 1978 |
Effect of drugs on the early and late phase UV erythema.
Topics: Adult; Anti-Inflammatory Agents; Erythema; Female; Humans; Indomethacin; Male; Middle Aged; Photosen | 1992 |
Treatment of actinic prurigo with PUVA: mechanism of action.
Topics: Adult; Dose-Response Relationship, Radiation; Female; Humans; Indomethacin; Photosensitivity Disorde | 1989 |
Effect of indomethacin on UVB- and UVA-induced erythema in polymorphic light eruption.
Topics: Administration, Topical; Adult; Aged; Erythema; Female; Humans; Indomethacin; Middle Aged; Photosens | 1989 |
Preparation and antiinflammatory activity of some nonacidic trisubstituted imidazoles.
Topics: Administration, Oral; Adrenal Glands; Adrenalectomy; Animals; Anti-Inflammatory Agents; Carrageenan; | 1974 |
Adverse reaction profiles of drug eruptions.
Topics: Ampicillin; Analgesics; Aspirin; Chlorpromazine; Drug-Related Side Effects and Adverse Reactions; Er | 1972 |